The argument: CHN's 2021 Phase I award already unlocks Phase III sole-source procurement. Phase II is not required.
CHN Analytics LLC completed a STTR Phase I award in 2021. That award -- FA8649-21-P-0756, issued by AFWERX under topic AF20C-TCSO1 -- is on the public record. KNOWN Under 15 U.S.C. 638(r)(4)(B), any federal agency may now issue a sole-source Phase III award to CHN (or its legal continuant) without further competition justification, without a J&A under FAR 6.302, and without a FAR Part 5 synopsis. The only predicate required is documented derivation: the new work must "derive from, extend, or complete" the Phase I effort. Phase II is not required -- by statute, by SBA Policy Directive, and by every agency guidance document recovered in this research.
The practical significance is timing. The conventional assumption in GovCon is that SBIR phases run in sequence: Phase I proves feasibility, Phase II builds a prototype, Phase III scales. That sequence is common practice, not law. An Air Force contracting officer could sign a Phase III action memo for NorthAI's technology today, citing the 2021 Phase I as the predicate award, so long as the derives-from nexus is documented. INFERRED That is the argument this memo constructs. Each section below lays one piece of the foundation. The full CO action memo template lives at co-action-memo-template-v0.html.
15 U.S.C. 638(r)(4)(B) is the operative authority. The full text: "issue, without further justification, Phase III awards relating to technology, including sole source awards, to the SBIR and STTR award recipients that developed the technology." The phrase "without further justification" is the load-bearing clause. The FAR was amended in April 2023 (Federal Register 2023-06420) to codify this: contracting officers may award sole-source Phase III actions on the basis of 638(r)(4) alone, with no separate J&A. KNOWN
Because CHN held a STTR Phase I (not an SBIR Phase I), the Phase III definition is governed by subsection (e)(6)(C), which reads: "a third phase for work that derives from, extends, or completes efforts made under prior funding agreements under the STTR program." KNOWN The operative test is the same three-part derives-extend-complete formula that governs SBIR Phase III. The SBA Policy Directive (2019), Section 9, closes any residual ambiguity with explicit parallel construction: "A Federal Agency may enter into a Phase III SBIR/STTR agreement at any time with a Phase II Awardee. Similarly, a Federal Agency may enter into a Phase III SBIR/STTR agreement at any time with a Phase I Awardee." The Army SBIR/STTR program page repeats the same language. AFWERX's own execution guide states it a third time. Three independent agency sources, same reading. KNOWN
CHN Analytics LLC was awarded FA8649-21-P-0756 on 2021-02-19. The award was issued by AFWERX under the AF X20.C STTR Commercial Solutions Opening, topic AF20C-TCSO1 ("Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions"). KNOWN Award value was $49,500, period of performance ran through 2021-05-18, and Stephanie Hughes confirmed on the 2026-05-20 discovery call that the Phase I is complete. KNOWN No Phase II award appears in any public database. KNOWN CHN meets the minimum statutory threshold: it is the firm that developed the technology under a prior STTR Phase I funding agreement. The predicate award is on the public record.
There is one legal continuity question that must be answered before the CO signs anything. The domain chnanalytics.com currently 301-redirects to northai.io, which is the expected signal for a rebrand. But the statute requires that Phase III go to "the SBIR and STTR award recipients that developed the technology" -- meaning the firm that held FA8649-21-P-0756 must be the same legal entity, or must have been formally novated, to NorthAI. TO-CONFIRM If CHN Analytics LLC was renamed NorthAI, the award travels with the entity and no additional action is required. If NorthAI is a separately formed entity that acquired CHN's assets, a novation of FA8649-21-P-0756 is needed before Phase III can issue. Tim needs to answer this question. It is a gating condition for the CO action memo, not a barrier to the thesis.
The Phase I verbatim scope from USASpending is the anchor: "Research in attempt to discover a new method for identifying commercialization partners for government-funded research output using multiple, connected big data sets (patents, grants, financial) powered by artificial intelligence." KNOWN That description identifies the data sources (patents, grants, financial), the method (AI over connected big data), and the goal (identify commercialization partners for government research). NorthAI's Tech Vector product is the productized commercial implementation of exactly that method -- same data sources, same AI-over-corpus approach, same function of surfacing who is doing what in a technology domain. KNOWN The DERIVES FROM prong is the strongest of the three for Tech Vector: the Phase I verbatim and the product description are both primary sources, and the textual match is direct.
NorthStar and Defense BD map to the EXTENDS prong. The AFWERX execution guide defines "extends" as "work for other applications not researched or performed in prior SBIR/STTR efforts." KNOWN NorthStar adds a conversational SLM interface layered over the same 200-million-document corpus -- a different access modality not researched in Phase I. Defense BD takes the financial-data dimension of the Phase I methodology and builds a dedicated RDT&E budget-intelligence product on it. Both are credible extensions of the Phase I work. INFERRED The detailed product-to-prong mapping, with the full derives-extend-complete analysis for all three products, is at derive-extend-complete-mapping-v0.html. Tim's Phase I technical report, once reviewed under NDA, would upgrade Defense BD from INFERRED to KNOWN by resolving what "financial" meant in the original Phase I scope.
A search across SBIR.gov, USASpending filters, GAO bid-protest decisions, and AFWERX public announcements returned zero publicly confirmed direct Phase I-only Phase III contracts. KNOWN That finding requires a careful read. The absence of confirmed cases is not evidence that such awards do not happen. It is evidence that public databases do not track base phase. SBIR.gov's awards database excludes Phase III from its phase filter entirely. USASpending carries Phase III contracts but has no base-phase field. Press releases announce the Phase III value; they do not narrate the phase history. The Joby Agility Prime ($131M) and Archer eVTOL ($142M) awards both show Phase III contracts where prior-phase breakdown is genuinely unknown from public records -- they may be Phase I-only. The data gap is structural, not evidentiary. INFERRED
The stronger argument is statutory, not precedential. No GAO case has ever invalidated a Phase III award for lacking Phase II. In every protest case found in this research, challengers attacked the derives-from nexus or a novation gap -- never the absence of Phase II. B-418028 (American Systems / DHA, $11.6M) confirmed Phase I alone is sufficient as the predicate award; the case was about a novation failure, not a Phase II requirement. B-418765 set the lowest-bar articulation of the derives-from test: the CO needed only show "some of the original concepts, findings, and ideas from Phase I." GAO consistently characterizes Phase III as agencies having "broad discretion" with "relatively limited requirements." KNOWN The full precedent scan, including all eight table entries and the GAO protest pattern analysis, is at p1-to-p3-direct-precedent-v0.html. Lead with statute. The precedent gap is honest to disclose and does not undermine the thesis.
Phase III does not happen because a company submits a proposal. It happens because a contracting officer at a specific agency decides to buy a specific technology and structures the award as a Phase III sole-source action. The immediate action for NorthAI is relationship, not paperwork. The natural CO target is the office that funded or used the Phase I work -- most likely within AFWERX, OPD-DE, or the OUSD R&E technology-transfer function that CHN served during the 5.5-year OSI&A engagement. INFERRED That CO needs to see: a clear derives-from memo linking the current product to FA8649-21-P-0756, a funding source identified outside the SBIR/STTR budget lines (Phase III cannot be funded with SBIR dollars -- permissible sources are RDT&E appropriations, O&M funds, and procurement accounts), and a statement that the CHN entity issue is resolved.
The CO action memo is the friction-reduction tool. The CO's obligation is narrow: prepare a memo for the record documenting that the work "derives from, extends, or completes efforts made under prior SBIR/STTR Phase I or II awards and is authorized pursuant to 15 U.S.C. 638(r)(4)." KNOWN No J&A. No synopsis. No separate sole-source justification. The Army SBIR program page's standard CO affirmation language: "It is sufficient to state that the project is an SBIR/STTR Phase III award that is derived from, extends, or completes efforts made under prior SBIR/STTR Funding Agreements and is authorized pursuant to 15 U.S.C. 638(r)(4), and further justification is not needed." The template at co-action-memo-template-v0.html pre-populates all seven required sections for CHN/NorthAI, drawing on R5 research and the USASpending facts from FA8649-21-P-0756.
The funding identification step is often where Phase III stalls. The CO needs a program element (PE) number or an O&M account that can absorb the award. For an AFWERX-originated STTR, the most natural source is the same OUSD R&E or Air Force Research Laboratory (AFRL) budget line that funds ongoing technology-scout work. INFERRED If the OSI&A engagement was funded through a contract vehicle, that vehicle may already have the right appropriation structure. Tim can identify the funding source faster than a CO can, and that identification is the single most useful thing NorthAI can bring to the first CO conversation. Dollar value is uncapped -- Phase III awards have no prescribed ceiling under 638(r)(4). AFWERX has issued Phase III IDIQs in the $99M to $142M range. The contract scope should reflect what the CO's office actually needs and what NorthAI's product can credibly deliver at this stage. KNOWN
The two conditional flags from the X2 conservative-reading test are the primary risks. First, the "financial" data semantic ambiguity: the Phase I USASpending description lists "patents, grants, financial" as the connected data sets. If "financial" in that context meant commercial investment data (VC rounds, funding rounds), Defense BD's extension argument is strongest. If it meant government budget or appropriations data, the Tech Vector DERIVES FROM argument is even cleaner but the Defense BD framing needs adjustment. TO-CONFIRM This is resolvable with Tim's Phase I technical report and does not change the thesis -- it changes which product leads the derives-from argument. Second, the NorthAI/CHN legal continuity question: if NorthAI is not the renamed entity of CHN Analytics LLC, a formal novation of FA8649-21-P-0756 must be executed before Phase III can issue. TO-CONFIRM The novation process is not blocking -- B-418028 shows a company that lost a Phase III award over a novation gap and re-won it within months after fixing the paperwork. But it is a timeline dependency that should be resolved before the CO conversation starts.
CO unfamiliarity is the softer risk. A CO at a specific office may have never issued a Phase I-only Phase III award. That does not mean they cannot -- it means the derives-from memo and the statutory citation need to be unusually clear. The site and the template artifacts are designed to reduce that friction. Agency variance is also real: Air Force / AFWERX is the most active Phase III issuer and is likely the lowest-resistance path given the Phase I history. An Army or Navy CO starting from scratch with no relationship to CHN's prior work would be a harder sell. INFERRED The playbook here is CO relationship first, derives-from documentation second, funding source identification third. None of those steps require a Phase II award to have happened.